PDB Short entry for 2LAV
HEADER    TRANSFERASE                             21-MAR-11   2LAV              
TITLE     NMR SOLUTION STRUCTURE OF HUMAN VACCINIA-RELATED KINASE 1             
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: VACCINIA-RELATED KINASE 1;                                 
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: SERINE/THREONINE-PROTEIN KINASE VRK1;                       
COMPND   5 EC: 2.7.11.1;                                                        
COMPND   6 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: VRK1;                                                          
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   8 EXPRESSION_SYSTEM_VECTOR: PET29B                                     
KEYWDS    VRK1, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, MITOSIS, CELL     
KEYWDS   2 CYCLE                                                                
EXPDTA    SOLUTION NMR                                                          
NUMMDL    20                                                                    
AUTHOR    J.SHIN,H.S.YOON                                                       
REVDAT   3   06-JUL-11 2LAV    1       JRNL                                     
REVDAT   2   18-MAY-11 2LAV    1       JRNL                                     
REVDAT   1   04-MAY-11 2LAV    0                                                
JRNL        AUTH   J.SHIN,G.CHAKRABORTY,N.BHARATHAM,C.KANG,N.TOCHIO,S.KOSHIBA,  
JRNL        AUTH 2 T.KIGAWA,W.KIM,K.T.KIM,H.S.YOON                              
JRNL        TITL   NMR SOLUTION STRUCTURE OF HUMAN VACCINIA-RELATED KINASE 1    
JRNL        TITL 2 (VRK1) REVEALS THE C-TERMINAL TAIL ESSENTIAL FOR ITS         
JRNL        TITL 3 STRUCTURAL STABILITY AND AUTOCATALYTIC ACTIVITY.             
JRNL        REF    J.BIOL.CHEM.                  V. 286 22131 2011              
JRNL        REFN                   ISSN 0021-9258                               
JRNL        PMID   21543316                                                     
JRNL        DOI    10.1074/JBC.M110.200162                                      
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS 1.2                                              
REMARK   3   AUTHORS     : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ         
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 2LAV COMPLIES WITH FORMAT V. 3.20, 01-DEC-08                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-MAR-11.                  
REMARK 100 THE RCSB ID CODE IS RCSB102171.                                      
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 298                                
REMARK 210  PH                             : 6.8                                
REMARK 210  IONIC STRENGTH                 : 20                                 
REMARK 210  PRESSURE                       : NULL                               
REMARK 210  SAMPLE CONTENTS                : 0.3-0.5 MM [U-100% 13C; U-100%     
REMARK 210                                   15N; U-80% 2H] VACCINIA RELATED-   
REMARK 210                                   KINASE 1, 0.3-0.5 MM [U-100% 15N;  
REMARK 210                                   U-50% 2H] VACCINIA RELATED-KINASE  
REMARK 210                                   1, 0.1-0.2 MM [U-100% 15N]         
REMARK 210                                   VACCINIA RELATED-KINASE 1, 90%     
REMARK 210                                   H2O/10% D2O; 0.3-0.5 MM [U-100%    
REMARK 210                                   13C; U-100% 15N; U-70% 2H]         
REMARK 210                                   VACCINIA RELATED-KINASE 1, 0.3-    
REMARK 210                                   0.5 MM [13C;15N]-VAL,ILE,LEU; [U-  
REMARK 210                                   100% 2H] VACCINIA RELATED-KINASE   
REMARK 210                                   1, 100% D2O                        
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 2D 1H-15N HSQC; 3D HNCACB; 3D      
REMARK 210                                   HN(CO)CACB; 3D HNCO; 3D HN(CA)CO;  
REMARK 210                                   3D 1H-15N NOESY; 3D 1H-13C NOESY;  
REMARK 210                                   3D HCCH-TOCSY                      
REMARK 210  SPECTROMETER FIELD STRENGTH    : 700 MHZ; 800 MHZ; 900 MHZ          
REMARK 210  SPECTROMETER MODEL             : AVANCE                             
REMARK 210  SPECTROMETER MANUFACTURER      : BRUKER                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : NMRPIPE, SPARKY, CYANA             
REMARK 210   METHOD USED                   : SIMULATED ANNEALING                
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : 100                                
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 20                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : STRUCTURES WITH THE LOWEST ENERGY  
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500  1 SER A  13      -61.48   -160.61                                   
REMARK 500  1 LYS A  16      175.76     60.56                                   
REMARK 500  1 LEU A  19      112.32     61.02                                   
REMARK 500  1 ASP A  31      172.86    -57.74                                   
REMARK 500  1 ASN A  57       88.81    -58.15                                   
REMARK 500  1 SER A  58      -76.83   -108.19                                   
REMARK 500  1 SER A  59     -173.15   -179.38                                   
REMARK 500  1 GLU A  60     -165.09     43.92                                   
REMARK 500  1 LYS A 106      -77.17    -82.75                                   
REMARK 500  1 LYS A 179      171.30    -54.33                                   
REMARK 500  1 ASP A 197       76.35     59.60                                   
REMARK 500  1 LEU A 200       31.58   -176.63                                   
REMARK 500  1 CYS A 205       57.65   -143.58                                   
REMARK 500  1 TYR A 213       89.74    -57.31                                   
REMARK 500  1 ASP A 216       64.89   -154.98                                   
REMARK 500  1 PHE A 227       29.28   -157.06                                   
REMARK 500  1 TRP A 261       45.25    -96.85                                   
REMARK 500  1 ASN A 264       36.12   -151.79                                   
REMARK 500  1 ASN A 281       77.70   -114.17                                   
REMARK 500  1 ASN A 294       93.35   -167.66                                   
REMARK 500  1 LEU A 308       31.32    -96.14                                   
REMARK 500  1 LEU A 316       72.38   -112.10                                   
REMARK 500  1 ASP A 335       92.34    -58.37                                   
REMARK 500  1 LYS A 338     -167.33     64.16                                   
REMARK 500  1 LEU A 339       74.04    -67.72                                   
REMARK 500  1 LEU A 341       46.61   -143.49                                   
REMARK 500  1 VAL A 343      -36.21   -157.43                                   
REMARK 500  1 VAL A 344      136.01     82.07                                   
REMARK 500  1 GLU A 345       76.39    176.38                                   
REMARK 500  1 ALA A 351       99.14   -163.00                                   
REMARK 500  1 THR A 353      -44.26   -160.65                                   
REMARK 500  1 ILE A 354      175.23    -47.64                                   
REMARK 500  1 THR A 355       80.80   -154.04                                   
REMARK 500  1 LYS A 356       57.45   -176.39                                   
REMARK 500  1 ARG A 358      -65.86   -162.83                                   
REMARK 500  1 LYS A 360       86.83     60.62                                   
REMARK 500  2 ARG A   3      -60.06   -106.14                                   
REMARK 500  2 ALA A   7      -46.45   -154.25                                   
REMARK 500  2 GLN A   8      107.32     60.34                                   
REMARK 500  2 ARG A  11      103.62     60.27                                   
REMARK 500  2 GLN A  12      -44.17   -164.77                                   
REMARK 500  2 SER A  14      -51.25   -140.86                                   
REMARK 500  2 ALA A  15      -69.28   -172.81                                   
REMARK 500  2 LYS A  16       32.09   -164.64                                   
REMARK 500  2 LEU A  19      -42.23   -171.11                                   
REMARK 500  2 ALA A  20      174.77    -59.12                                   
REMARK 500  2 GLU A  21       76.31   -179.13                                   
REMARK 500  2 GLN A  22      -75.49   -176.34                                   
REMARK 500  2 PHE A  48      -77.78     65.20                                   
REMARK 500  2 ASN A  57       98.86    -59.35                                   
REMARK 500                                                                      
REMARK 500 THIS ENTRY HAS     788 RAMACHANDRAN OUTLIERS.                        
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 16715   RELATED DB: BMRB                                 
DBREF  2LAV A    1   361  UNP    Q99986   VRK1_HUMAN       1    361             
SEQRES   1 A  361  MET PRO ARG VAL LYS ALA ALA GLN ALA GLY ARG GLN SER          
SEQRES   2 A  361  SER ALA LYS ARG HIS LEU ALA GLU GLN PHE ALA VAL GLY          
SEQRES   3 A  361  GLU ILE ILE THR ASP MET ALA LYS LYS GLU TRP LYS VAL          
SEQRES   4 A  361  GLY LEU PRO ILE GLY GLN GLY GLY PHE GLY CYS ILE TYR          
SEQRES   5 A  361  LEU ALA ASP MET ASN SER SER GLU SER VAL GLY SER ASP          
SEQRES   6 A  361  ALA PRO CYS VAL VAL LYS VAL GLU PRO SER ASP ASN GLY          
SEQRES   7 A  361  PRO LEU PHE THR GLU LEU LYS PHE TYR GLN ARG ALA ALA          
SEQRES   8 A  361  LYS PRO GLU GLN ILE GLN LYS TRP ILE ARG THR ARG LYS          
SEQRES   9 A  361  LEU LYS TYR LEU GLY VAL PRO LYS TYR TRP GLY SER GLY          
SEQRES  10 A  361  LEU HIS ASP LYS ASN GLY LYS SER TYR ARG PHE MET ILE          
SEQRES  11 A  361  MET ASP ARG PHE GLY SER ASP LEU GLN LYS ILE TYR GLU          
SEQRES  12 A  361  ALA ASN ALA LYS ARG PHE SER ARG LYS THR VAL LEU GLN          
SEQRES  13 A  361  LEU SER LEU ARG ILE LEU ASP ILE LEU GLU TYR ILE HIS          
SEQRES  14 A  361  GLU HIS GLU TYR VAL HIS GLY ASP ILE LYS ALA SER ASN          
SEQRES  15 A  361  LEU LEU LEU ASN TYR LYS ASN PRO ASP GLN VAL TYR LEU          
SEQRES  16 A  361  VAL ASP TYR GLY LEU ALA TYR ARG TYR CYS PRO GLU GLY          
SEQRES  17 A  361  VAL HIS LYS GLU TYR LYS GLU ASP PRO LYS ARG CYS HIS          
SEQRES  18 A  361  ASP GLY THR ILE GLU PHE THR SER ILE ASP ALA HIS ASN          
SEQRES  19 A  361  GLY VAL ALA PRO SER ARG ARG GLY ASP LEU GLU ILE LEU          
SEQRES  20 A  361  GLY TYR CYS MET ILE GLN TRP LEU THR GLY HIS LEU PRO          
SEQRES  21 A  361  TRP GLU ASP ASN LEU LYS ASP PRO LYS TYR VAL ARG ASP          
SEQRES  22 A  361  SER LYS ILE ARG TYR ARG GLU ASN ILE ALA SER LEU MET          
SEQRES  23 A  361  ASP LYS CYS PHE PRO GLU LYS ASN LYS PRO GLY GLU ILE          
SEQRES  24 A  361  ALA LYS TYR MET GLU THR VAL LYS LEU LEU ASP TYR THR          
SEQRES  25 A  361  GLU LYS PRO LEU TYR GLU ASN LEU ARG ASP ILE LEU LEU          
SEQRES  26 A  361  GLN GLY LEU LYS ALA ILE GLY SER LYS ASP ASP GLY LYS          
SEQRES  27 A  361  LEU ASP LEU SER VAL VAL GLU ASN GLY GLY LEU LYS ALA          
SEQRES  28 A  361  LYS THR ILE THR LYS LYS ARG LYS LYS GLU                      
HELIX    1   1 GLY A   78  ALA A   91  1                                  14    
HELIX    2   2 LYS A   92  LYS A  104  1                                  13    
HELIX    3   3 ASP A  137  ASN A  145  1                                   9    
HELIX    4   4 SER A  150  GLU A  170  1                                  21    
HELIX    5   5 LYS A  179  SER A  181  5                                   3    
HELIX    6   6 CYS A  205  VAL A  209  5                                   5    
HELIX    7   7 SER A  229  GLY A  235  1                                   7    
HELIX    8   8 ARG A  240  GLY A  257  1                                  18    
HELIX    9   9 LEU A  259  ASP A  263  5                                   5    
HELIX   10  10 ASP A  267  ASN A  281  1                                  15    
HELIX   11  11 ASN A  281  PHE A  290  1                                  10    
HELIX   12  12 PRO A  296  LEU A  308  1                                  13    
HELIX   13  13 LEU A  316  ILE A  331  1                                  16    
SHEET    1   A 6 GLU A  27  THR A  30  0                                        
SHEET    2   A 6 GLU A  36  ILE A  43 -1  O  VAL A  39   N  GLU A  27           
SHEET    3   A 6 ILE A  51  MET A  56 -1  O  ILE A  51   N  ILE A  43           
SHEET    4   A 6 CYS A  68  PRO A  74 -1  O  VAL A  70   N  TYR A  52           
SHEET    5   A 6 LYS A 124  ASP A 132 -1  O  MET A 131   N  VAL A  69           
SHEET    6   A 6 TYR A 113  LYS A 121 -1  N  GLY A 115   O  ILE A 130           
SHEET    1   B 2 LEU A 183  LEU A 185  0                                        
SHEET    2   B 2 VAL A 193  LEU A 195 -1  O  TYR A 194   N  LEU A 184           
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000